One of the most important health problems today both in industrialised and developing nations, is lung cancer. Although there are numerous therapeutic options, the prognosis for survival is still very dismal. Although altered metabolism is one of the characteristics of human cancer, lipid metabolism problems are less well understood. A deeper understanding of them could be useful to develop new methods for accurate diagnosis, prognosis estimation, and the creation of therapeutic agents based on bioactive substances like cerulenin, SCD1, ACLY inhibitors, statins, polyphenolic compounds, etc (Tsankova NM 2006). The basis of lipid metabolism in lung cancer is reviewed in this research along with potential indicators. To advance our understanding in this area, more research is very necessary.
Share this article